See All Slides - tctmd.com

Slides

Presentation TCT 2012

Year in Review: Arrhythmias

Presenter: John Camm

October 23, 2012

Presentation TCT 2012

BioMime (Meril Life Sciences) Program Update

Presenter: Ashok Seth

October 23, 2012

Presentation TCT 2012

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

Recanalization of Aortoiliac CTOs: Access Strategies and the Value of Occlusion Devices

Presenter: John Laird Jr

October 23, 2012

$TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...$

Presentation TCT 2012

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Presenter: Lamin King

October 23, 2012

Presentation TCT 2012

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Presenter: Joerg Kempfert

October 23, 2012

Presentation TCT 2012

Introduction(12)

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Synergy (Boston Scientific) Program Update

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

No: Changing Standards Would Be Premature!

Presenter: Robert Siegel

October 23, 2012

Presentation TCT 2012

Appropriateness Criteria: Implications for Clinical Practice

Presenter: Monica Losquadro

October 23, 2012

Advertisement

Slides

Year in Review: Arrhythmias

BioMime (Meril Life Sciences) Program Update

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

Recanalization of Aortoiliac CTOs: Access Strategies and the Value of Occlusion Devices

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Introduction(12)

Synergy (Boston Scientific) Program Update

No: Changing Standards Would Be Premature!

Appropriateness Criteria: Implications for Clinical Practice

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content